Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.

Acta pharmaceutica (Zagreb, Croatia) - 1 Mar 2006

Juretić Dubravka, Motejlkova Alena, Kunović Branka, Rekić Branka, Flegar-Mestrić Zlata, Vujić Lovorka, Mesić Ranko, Lukac-Bajalo Jana, Simeon-Rudolf Vera

Abstract excerpt

The aim of this study was to determine whether the paraoxonase (PON1) status, i.e. PON1 activities and phenotypes (AA, AB and BB), and its relationship with lipid status are different in patients with type II diabetes as compared to healthy population. Diabetic group comprised 175 patients with t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aryldialkylphosphatase

Share to Carboxylic Ester Hydrolases

Share to Cholesterol, LDL

Share to Diabetes Mellitus, Type 2

Share to Triglycerides

Source

Identifiers

PMID: 16613735

Genes

PON1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16613735-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.PMID 16613735Read ↗

Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.Semantic proximity Read ↗

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.Semantic proximity Read ↗

Paraoxonase phenotype distribution in a healthy Iranian population.Semantic proximity Read ↗

Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.Semantic proximity Read ↗

Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.Semantic proximity Read ↗

Enzyme Activity and Genetic Polymorphisms of Paraoxonase 1 in Patients With Type 2 Diabetes Mellitus: A Case-Control StudySemantic proximity Read ↗

Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).Semantic proximity Read ↗

Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.Semantic proximity Read ↗

Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus.Semantic proximity Read ↗

The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.Semantic proximity Read ↗

Paraoxonase activity in healthy, diabetic, and hemodialysis patients.Semantic proximity Read ↗

Paraoxonase gene polymorphism and coronary artery disease in Indian subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.